InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Kirby Daniel Gordon. Director active across 1 company, notably Iovance Biotherapeutics, INC.. Aggregated, 5 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €48k. History available since 5 June 2025. The latest transaction was filed on 10 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Kirby Daniel Gordon is linked to Iovance Biotherapeutics, INC. as Chief Commercial Officer. He has 5 filings in total, and across the 5 recent filings sampled, buys total EUR 48193, sells total EUR 0, with the main transaction nature listed as Option exercise between 2025-06-06 and 2026-08-12.